{"filings":[{"id":49485,"accession_number":"0001140361-26-020906","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2026-05-13T10:01:44+00:00","items":["7.01"],"status":"ready","headline":"Cigna reaffirms FY 2026 adjusted EPS guidance of at least $30.35","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reaffirms full-year 2026 consolidated adjusted income from operations per share of at least $30.35.","Guidance was first provided in the April 30, 2026 press release and conference call.","Reaffirmation made during investor meetings over the next several weeks."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95111,"accession_number":"0001140361-26-017971","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cigna Q1 adj EPS $7.79 beats $6.74 YoY; raises FY2026 outlook to at least $30.35/share","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP EPS $6.26 vs $4.85 YoY; adjusted EPS $7.79 vs $6.74; revenues $68.5B +5%.","Evernorth adj revenues $58.4B +9%; adj pre-tax income $1.47B +2%.","Cigna Healthcare adj revenues $11.5B (-21% due to HCSC); adj pre-tax $1.51B +18%; MCR 79.8% improved.","FY2026 adj EPS outlook raised to at least $30.35 (up $0.10); Cigna Healthcare adj pre-tax outlook at least $4.525B.","Total customers 185.5M; medical customers 18.3M (+1% seq); pharmacy 121M (-2% seq)."],"consensus_eps_estimate":7.841,"consensus_eps_actual":6.26,"consensus_revenue_estimate":null,"consensus_revenue_actual":68494000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95110,"accession_number":"0001140361-26-017123","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2026-04-27T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Cigna annual meeting: all director nominees elected, say-on-pay passes, written consent proposal fails","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders elected all 12 director nominees; each received >80% of votes cast (excluding broker non-votes).","Advisory vote on executive compensation passed with 92% support (201.7M for, 17.4M against).","Ratification of PwC as auditor for 2026 approved: 216.1M for, 21.0M against.","Shareholder proposal on right to act by written consent failed: 105.0M for vs 114.2M against.","Turnout of 89.97% of outstanding shares (237.2M of 263.7M) represented at the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107949,"accession_number":"0001140361-26-007450","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2026-03-03T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Cigna appoints Brian Evanko as CEO; David Cordani to become Executive Chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brian Evanko succeeds David Cordani as CEO effective July 1, 2026; Cordani becomes Executive Chair.","Evanko elected to Board effective April 1, 2026; Eric Foss named Lead Independent Director.","Evanko compensation: base salary $1.3M, EIP target $2.6M, LTI target $15.1M, plus $3.5M transitional equity.","Company reaffirms FY2026 adjusted EPS guidance of at least $30.25, Evernorth pre-tax at least $6.9B, Cigna Healthcare at least $4.5B.","Cordani's tenure: revenue grew from $18B to $275B, customers from 46M to 180M, TSR >750%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107948,"accession_number":"0001140361-26-007049","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2026-02-27T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Cigna reaffirms FY 2026 adjusted EPS guidance of at least $30.25","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reaffirms full-year 2026 consolidated adjusted EPS of at least $30.25 per share.","Guidance was originally disclosed in February 5, 2026 press release and investor call.","Management expects to discuss outlook with investors and analysts over the next several weeks."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107947,"accession_number":"0001140361-26-003768","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2026-02-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cigna Q4 adj EPS $8.08 beats; FY adj EPS $29.84; dividend raised; 2026 guide at least $30.25","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY 2025 adjusted income from operations $8.0B ($29.84/share), +4% vs $7.7B ($27.33) in 2024.","Q4 2025 adjusted income from operations $2.1B ($8.08/share), +16% vs $1.8B ($6.64) in Q4 2024.","Total revenues FY 2025 $274.9B, +11% YoY, driven by Evernorth Health Services growth.","Board raised quarterly dividend to $1.56/share from $1.51, payable March 19, 2026.","2026 outlook: adj income from operations at least $7.95B (≥$30.25/share); adj revenues ~$280B."],"consensus_eps_estimate":8.1131,"consensus_eps_actual":22.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":274900000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124363,"accession_number":"0001140361-25-042597","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2025-11-18T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Cigna Board revamps committee structure; Compliance Committee dissolved, tech oversight consolidated","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Compliance Committee dissolved as separate standing committee effective Jan 1, 2026; responsibilities assumed by Board and other committees.","Audit Committee renamed 'Audit and Compliance Committee' with enterprise compliance oversight.","Corporate Governance Committee adds oversight of ethics program and public clinical reporting.","Finance Committee renamed 'Finance and Technology Committee' overseeing technology, AI, cybersecurity, and disaster recovery."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124362,"accession_number":"0001140361-25-039777","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cigna Q3 revenue up 10% to $69.7B, adjusted EPS $7.83, reaffirms FY2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $69.7B (+10% YoY); GAAP net income $1.9B ($6.98 EPS) vs $0.7B ($2.63) in Q3 2024.","Adjusted EPS $7.83 vs $7.51 YoY; reaffirms FY2025 adjusted EPS outlook at least $29.60.","Evernorth segment revenue +15%, adj income +1%; Cigna Healthcare rev -18% due to HCSC divestiture.","Announced new rebate-free pharmacy benefit model to lower costs and improve transparency."],"consensus_eps_estimate":7.8773,"consensus_eps_actual":17.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":202428000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124361,"accession_number":"0001140361-25-038670","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2025-10-20T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director General Elder Granger to retire from Cigna Board on Dec 31, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Retired Major General Elder Granger, M.D. will retire from The Cigna Group Board effective December 31, 2025.","Retirement is consistent with the Board's retirement age policy and not due to any disagreement.","No replacement has been announced in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141033,"accession_number":"0001140361-25-033986","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2025-09-04T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Cigna issues $4.5B senior notes across four tranches, uses proceeds to repay term loan","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $4.5B senior notes in four tranches: $1B 4.500% due 2030, $1.25B 4.875% due 2032, $1.5B 5.250% due 2036, $750M 6.000% due 2056.","Proceeds: $2.0B to repay Term Loan used for strategic investment; remainder for general corporate purposes including investments and debt repayment.","Notes have make-whole redemption provisions until 1-6 months before maturity, then par call.","Underwriting agreement with BofA, Citigroup, HSBC, Morgan Stanley dated September 2, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141032,"accession_number":"0001140361-25-033536","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2025-09-02T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Cigna reaffirms FY2025 adjusted EPS of at least $29.60","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Officials will reaffirm full-year 2025 consolidated adjusted income from operations of at least $29.60 per share.","Reaffirmation is consistent with guidance previously issued on July 31, 2025.","No new financial results or changes to prior outlook were disclosed.","Adjusted income from operations is a non-GAAP measure; no reconciliation provided on a forward-looking basis."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141031,"accession_number":"0001140361-25-028099","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cigna Q2 2025 adj. EPS $7.20 beats prior year; revenue $67.2B; reaffirms FY adj. EPS $29.60+","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Shareholders' net income of $1.5B ($5.71 diluted EPS); adjusted income from operations $1.9B ($7.20 per share), up 7% YoY.","Evernorth Health Services adjusted revenues up 17% to $57.8B; adjusted income up 5% to $1.70B pre-tax.","Cigna Healthcare adjusted revenues down 18% to $10.8B due to HCSC divestiture; MCR 83.2% vs 82.3% YoY.","Total medical customers 18.0M, down 6% from Dec 2024 reflecting HCSC sale; pharmacy customers up 3% to 121.9M.","2025 outlook reaffirmed: consolidated adj. EPS at least $29.60; Evernorth adj. income $7.2B; Cigna Healthcare adj. income $4.125B."],"consensus_eps_estimate":7.3685,"consensus_eps_actual":10.55,"consensus_revenue_estimate":null,"consensus_revenue_actual":132680000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141030,"accession_number":"0001140361-25-027585","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K/A","filed_at":"2025-07-28T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Cigna appoints Michael J. Hennigan to Audit and Corporate Governance Committees","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board appointed Michael J. Hennigan to Audit and Corporate Governance Committees on July 22, 2025.","Hennigan previously joined the Board as an independent member effective June 2, 2025.","Committee assignments were not disclosed at initial appointment; this amendment provides the details."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158814,"accession_number":"0001140361-25-021143","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2025-06-02T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cigna appoints Michael J. Hennigan, Executive Chairman of Marathon Petroleum, to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael J. Hennigan appointed as independent director effective June 2, 2025.","Hennigan is Executive Chairman of Marathon Petroleum Corporation and MPLX.","He will participate in Cigna's non-employee director compensation plan (effective July 24, 2024).","No arrangements or transactions requiring Item 404(a) disclosure exist."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158813,"accession_number":"0001140361-25-019807","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2025-05-20T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Cigna reaffirms FY2025 adjusted EPS guidance of at least $29.60","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Reaffirmed full-year 2025 adjusted EPS target of at least $29.60 per share.","Guidance originally provided on May 2, 2025; reaffirmation made on May 20, 2025.","Affirmation comes ahead of investor meetings over the coming weeks.","Adjusted income from operations excludes investment gains/losses, amortization, and special items."],"consensus_eps_estimate":null,"consensus_eps_actual":4.85,"consensus_revenue_estimate":null,"consensus_revenue_actual":65502000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158812,"accession_number":"0001140361-25-017006","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2025-05-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cigna Q1 net income $1.3B ($4.85/sh) vs net loss year ago; raises FY25 adj EPS view to at least $29.60","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenues $65.5B, up 14% YoY; adjusted EPS $6.74 vs $6.47 prior year.","Shareholders' net income $1.3B ($4.85/sh) vs net loss $0.3B ($0.97/sh) in Q1 2024.","FY2025 adjusted EPS outlook raised to at least $29.60, up $0.10 from prior.","Completed divestiture of Medicare businesses to HCSC on Mar 19, 2025; customers impacted.","Year-to-date repurchased 8.2M shares for $2.6B."],"consensus_eps_estimate":null,"consensus_eps_actual":4.85,"consensus_revenue_estimate":null,"consensus_revenue_actual":65502000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158811,"accession_number":"0001140361-25-016027","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2025-04-28T23:59:59+00:00","items":["1.01","1.02","2.03","5.02","5.07"],"status":"ready","headline":"Cigna upsizes revolving credit facility to $6.5B; CIO Eder resigns","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $6.5B revolving credit and letter of credit facility replaces prior $5.0B agreement.","Facility includes options to increase commitments to $8.0B and extend maturity by one-year periods.","CIO Noelle Eder resigns effective May 16, 2025, for personal reasons; no disagreement with company.","Annual meeting: all 11 director nominees elected, say-on-pay approved, PwC ratified, shareholder proposal defeated.","Leverage covenant set at max 0.60:1 (0.65 after acquisitions over $1B cash consideration)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158810,"accession_number":"0001140361-25-014574","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2025-04-18T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Cigna finalizes severance agreement with departing EVP Eric Palmer; $10M total value","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Eric Palmer's employment ends April 26, 2025; severance includes $5.2M cash and ~$4.8M in equity value.","Cash comprises 78 weeks base pay, 150% of 2025 EIP target, prorated EIP, and 18-month COBRA subsidy.","Equity: options/RSUs/SPSs vesting within 12 months continue; SPS paid on actual performance at $328.63/share.","Agreement includes customary confidentiality, non-solicitation, non-competition, and non-disparagement clauses."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177217,"accession_number":"0001140361-25-009365","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2025-03-19T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Cigna completes sale of Medicare businesses to HCSC; proceeds for buybacks","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sale closed March 19, 2025; includes Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies.","Health Care Service Corporation (HCSC) is the buyer; deal previously announced.","Majority of proceeds expected to be allocated to share repurchases per capital deployment priorities.","Cigna will continue providing pharmacy benefits via Evernorth Health Services under services agreements with HCSC.","Coverage for customers remains unchanged; no disruption to service."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177216,"accession_number":"0001140361-25-008555","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2025-03-13T23:59:59+00:00","items":["5.02","7.01"],"status":"ready","headline":"Cigna names Evanko President/COO, Dennison CFO; reaffirms FY2025 EPS guide","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Brian Evanko becomes President and COO effective March 31, 2025; base salary $1.1M, LTI target $6.7M.","Ann Dennison named EVP, CFO effective same date; base salary $800K, LTI target $3.5M plus transitional grant $750K.","Eric Palmer's employment as EVP Enterprise Strategy ends April 26, 2025; separation terms to be disclosed.","Reaffirms FY2025 adjusted EPS at least $29.50; Evernorth $7.2B; Cigna Healthcare $4.1B pre-tax income."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177215,"accession_number":"0001140361-25-006753","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2025-03-03T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Cigna reaffirms FY2025 adjusted EPS guidance of at least $29.50","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Reaffirmed full-year 2025 consolidated adjusted income from operations per share of at least $29.50.","Outlook reaffirmed ahead of upcoming investor meetings scheduled over the next several weeks.","Original guidance was provided on January 30, 2025 during Q4 earnings release and investor call.","Adjusted income from operations is a non-GAAP metric; excludes investment gains/losses, amortization, and special items.","No reconciliation to GAAP provided due to unpredictable components; management cites inherent uncertainty."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177214,"accession_number":"0001140361-25-002386","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2025-01-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cigna Q4 adj ops income down 8% on stop loss costs; 2025 EPS guidance at least $29.50; dividend +8%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 adjusted income from operations $1.8B ($6.64/sh), down from $2.0B ($6.79/sh) YoY; revenue $65.6B (+28%).","Full-year 2024 adjusted income $7.7B ($27.33/sh), up 4% from 2023; GAAP net income $3.4B impaired by $2.7B VillageMD write-down.","2025 outlook: adjusted EPS at least $29.50; adjusted ops income at least $7.9B; Cigna Healthcare MCR guided 83.2%-84.2%.","Board declared $1.51 quarterly dividend (+8% from $1.40) and $6.0B incremental buyback authorization, total $10.3B.","Cigna Healthcare Q4 MCR 87.9% vs 82.2% YoY; segment adj pre-tax income down 47% due to higher stop loss medical costs."],"consensus_eps_estimate":null,"consensus_eps_actual":12.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":247121000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193984,"accession_number":"0001140361-24-044674","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2024-10-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cigna Q3 adj. EPS $7.51 beats $6.77 YoY; revenue up 30%; reaffirms FY24 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Adjusted income from operations $2.1B ($7.51/share) vs $2.0B ($6.77/share) in Q3 2023; net income includes $1.0B non-cash VillageMD loss.","Total revenues $63.7B, up 30% YoY, driven by Evernorth Health Services growth (revenues +36%).","Evernorth adj. income pre-tax $1.876B (+9%); Cigna Healthcare adj. income pre-tax $1.174B (-4%) with MCR 82.8% vs 80.5%.","Total customer relationships 183.5M (+12% vs Dec 2023); pharmacy customers 120M (+22%).","Reaffirms FY2024 adjusted EPS outlook of at least $28.40; segment guidance reaffirmed."],"consensus_eps_estimate":null,"consensus_eps_actual":7.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":181472000000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210318,"accession_number":"0000950159-24-000274","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2024-09-03T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Cigna reaffirms FY2024 adjusted EPS outlook of at least $28.40","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reaffirms full-year 2024 consolidated adjusted income from operations per share of at least $28.40.","Outlook unchanged from guidance issued August 1, 2024.","Management to participate in investor meetings over the next several weeks.","Reaffirmation does not provide a GAAP reconciliation due to uncertain items."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210317,"accession_number":"0000950159-24-000233","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cigna Q2 revenue $60.5B (+25% YoY); adj. EPS $6.72 beats $6.13 prior year","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total Q2 revenue $60.5B, +25% YoY; adjusted income from ops $1.9B, +5% YoY.","Adjusted EPS $6.72 vs $6.13 prior year; full-year outlook adj. EPS at least $28.40.","Evernorth segment adjusted revenues +30%, pre-tax income +7% to $1.619B.","Cigna Healthcare adjusted revenue +3%; MCR 82.3% (81.2% prior) due to $50M prior-year Medicare risk adjustment.","YTD through July 31 repurchased 14.7M shares for ~$5.0B."],"consensus_eps_estimate":null,"consensus_eps_actual":4.43,"consensus_revenue_estimate":null,"consensus_revenue_actual":117778000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228633,"accession_number":"0000950159-24-000218","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2024-06-20T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Cigna appoints Jamie Kates as Chief Accounting Officer effective July 1, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jamie Kates named Chief Accounting Officer and principal accounting officer, effective July 1, 2024.","Annual base salary of $400,000; 2024 EIP target at 50% of base (prorated).","2025 Long-Term Incentive target of $300,000; eligible for employee benefit plans.","Ms. Kates, 44, is a CPA who joined Cigna in 2009 and most recently served as VP, Accounting since Oct 2021.","She previously managed Evernorth Health Services accounting, compliance and consolidation functions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228632,"accession_number":"0000950159-24-000212","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2024-06-06T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Cigna reaffirms FY2024 adjusted EPS ≥ $28.40; completes $3.2B accelerated share repurchase","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reaffirms 2024 consolidated adjusted income from operations per share of at least $28.40.","Completed $3.2B accelerated share repurchase agreements in early June 2024.","Year-to-date repurchases total $4.4B through May 31, 2024; on track for $5.0B in first half of 2024.","Expects majority of discretionary cash flow to be used for share repurchases this year."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228631,"accession_number":"0000950159-24-000134","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cigna posts Q1 GAAP net loss $0.97/share on VillageMD impairment; adj EPS $6.47, outlook raised","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Shareholders' net loss $277M ($0.97 loss per share) includes $1.8B non-cash impairment of VillageMD equity securities.","Adjusted income from operations $1.875B ($6.47/share), up from $5.41 YoY; raises 2024 adj EPS outlook to at least $28.40.","Evernorth Health Services revenue $46.2B (+28% YoY); Cigna Healthcare MCR improved to 79.9% from 81.3%.","Total pharmacy customers 122.8M (+25% from Dec 2023); medical customers 19.2M; share buybacks $3.4B YTD.","Medicare sale to HCSC on track, expected close Q1 2025; cyber incident impacted claims processing and net medical costs payable."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.97,"consensus_revenue_estimate":null,"consensus_revenue_actual":57255000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228630,"accession_number":"0000950159-24-000132","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2024-04-26T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Cigna annual meeting: all 12 directors elected, say-on-pay passes, shareholder proposals fail","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 12 director nominees elected; votes ranged from ~223M (Zarcone) to ~236M (Hathi); broker non-votes ~19.7M.","Advisory vote on executive compensation approved: 197.2M for (83.4%), 39.2M against.","Ratification of PwC as auditor for 2024 passed: 237.5M for (93.3%), 18.9M against.","Shareholder proposal to improve special meeting right failed: 114.0M for, 119.6M against.","Shareholder proposal on DEI risks overwhelmingly defeated: 3.7M for, 231.4M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228629,"accession_number":"0000950159-24-000130","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2024-04-26T23:59:59+00:00","items":["1.01","8.01","2.03","9.01"],"status":"ready","headline":"Cigna enters new $6.5B revolving credit facilities, replacing existing lines","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Signed a $5.0B five-year revolver and a $1.5B 364-day revolver, effective April 25, 2024.","Facilities include an accordion option to increase total commitments by up to $1.5B to $8.0B.","Credit agreements replace Cigna's prior revolving credit facilities in full.","Leverage covenant: total consolidated debt to capitalization ratio cannot exceed 0.60:1 (or 0.65:1 post-large acquisition).","Interest rates based on SOFR plus an applicable margin depending on Cigna's credit ratings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247282,"accession_number":"0000950159-24-000103","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2024-03-07T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cigna raises long-term adjusted EPS growth target to 10%-14%; reaffirms FY2024 guidance of at least $28.25","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Long-term average annual adjusted EPS growth target raised to 10%-14% from prior target.","2024 adjusted EPS guidance reaffirmed at least $28.25 per share.","Launches EncircleRx: industry-first financial guarantee for GLP-1s to help cap employer costs.","Evernorth Behavioral Care Group launched; guarantees appointment within 72 hours, scales by 2025.","Evernorth plans Humira biosimilar at $0 out-of-pocket for eligible Accredo patients by end of 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247281,"accession_number":"0000950159-24-000100","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2024-02-15T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Cigna announces $3.2B accelerated share repurchase; initial delivery of ~7.6M shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Entered ASR agreements with Deutsche Bank and Bank of America to repurchase $3.2B of common stock.","Initial delivery of ~7.6 million shares on Feb 15, 2024, in exchange for $3.2B prepayment.","Part of existing repurchase program with $10.6B remaining authority; on track for $5B in H1 2024.","Final settlement expected in Q2 2024; additional shares or cash may be exchanged.","CEO David Cordani says buyback reflects business strength and commitment to shareholder value."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247280,"accession_number":"0001140361-24-007429","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2024-02-13T23:59:59+00:00","items":["1.01","2.03","7.01","8.01","9.01"],"status":"ready","headline":"Cigna issues $4.5B in senior notes across four tranches to fund tender offers and refinancing","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $1.0B 5.000% notes due 2029, $750M 5.125% notes due 2031, $1.25B 5.250% notes due 2034, $1.5B 5.600% notes due 2054.","Proceeds will fund tender offers for up to $2.25B of outstanding notes maturing 2024-2030.","Remaining proceeds to repay 0.613% Senior Notes due March 2024 and for general corporate purposes including share repurchases."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247279,"accession_number":"0001140361-24-005982","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2024-02-07T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Cigna issues $4.5B senior notes across four tranches; proceeds for debt refinancing and share buybacks","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $1B 5.000% notes due 2029, $750M 5.125% due 2031, $1.25B 5.250% due 2034, and $1.5B 5.600% due 2054.","Proceeds to fund tender offers for up to $2.25B of existing notes and repay 0.613% notes due 2024.","Remaining proceeds for general corporate purposes including debt repayment and share repurchases."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247278,"accession_number":"0000950159-24-000033","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2024-02-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cigna Group Reports Strong Q4 and Full Year 2023 Results, Raises 2024 EPS Outlook, Increases Dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full year 2023 total revenues were $195.3 billion, up 8% year-over-year.","Adjusted income from operations for 2023 was $7.4 billion, or $25.09 per share.","Board declared a 14% increase in quarterly dividend to $1.40 per share.","2024 adjusted EPS projected at least $28.25, up from prior outlook.","Company repurchased 7.8 million shares for $2.3 billion in 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":17.39,"consensus_revenue_estimate":null,"consensus_revenue_actual":195265000000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247277,"accession_number":"0000950159-24-000025","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2024-01-31T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Cigna sells Medicare businesses to HCSC for $3.7B; expects Q1 2025 close, accretive to adjusted EPS","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total transaction value ~$3.7B; includes Medicare Advantage, Supplemental Benefits, Part D, and CareAllies.","Expected to close in Q1 2025, subject to regulatory approvals; no financing condition.","Cigna expects to recognize a pre-tax loss of ~$1.5B in net income as of Dec 31, 2023, primarily from asset write-offs and costs to sell; does not affect adjusted income.","Transaction expected to be accretive to adjusted EPS in 2025; reaffirms 2024 adj. EPS target of at least $28 and 10-13% long-term annual growth.","Proceeds primarily allocated to share repurchases; four-year services agreement for Evernorth to continue providing PBM services."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247276,"accession_number":"0000950159-24-000017","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2024-01-22T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Cigna Group CAO Mary Agoglia Hoeltzel to retire effective July 1, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mary Agoglia Hoeltzel, SVP and Chief Accounting Officer, notified her intention to retire.","Retirement effective July 1, 2024; no immediate replacement announced.","Departure is voluntary and part of planned retirement, not a sudden exit."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":247275,"accession_number":"0000950159-24-000014","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2024-01-17T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Cigna reorganizes: Evanko adds Cigna Healthcare CEO role; Palmer gains enterprise strategy","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brian Evanko becomes President/CEO of Cigna Healthcare effective Feb 5, retains CFO role.","Eric Palmer adds EVP, Enterprise Strategy while remaining CEO of Evernorth Health Services.","Both executives receive base salary of $1M, 2024 EIP target $2M, LTI target $6M.","Changes reflect expanded responsibilities; committees approved compensation on Jan 16."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":264708,"accession_number":"0000950159-23-000321","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2023-12-29T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Cigna reaffirms 2023 adj. EPS guidance of at least $24.75, 2024 target at least $28.00","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reaffirmed FY2023 consolidated adjusted income from operations per share of at least $24.75.","Targeted FY2024 consolidated adjusted income from operations per share of at least $28.00.","Outlook reaffirmed ahead of investor meetings; prior guidance from November 2, 2023 earnings call.","Adjusted income from operations is a non-GAAP measure; reconciliation not provided on forward-looking basis."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":264707,"accession_number":"0000950159-23-000317","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2023-12-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cigna increases share repurchase authorization by $10B to $11.3B; plans $5B buyback by H1 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved $10B increase to share repurchase authorization; total authority now $11.3B.","Company intends to repurchase at least $5B of common stock by end of first half of 2024.","Portion of repurchase to be executed via accelerated share repurchase (ASR) program in Q1 2024.","Management believes shares are significantly undervalued; reaffirms FY2023 adjusted EPS outlook of at least $24.75.","Targets FY2024 consolidated adjusted EPS of at least $28.00; long-term adjusted EPS growth target of 10-13%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":264706,"accession_number":"0000950159-23-000315","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2023-12-04T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Cigna reaffirms FY2023 adjusted EPS guidance of at least $24.75","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Reaffirmed full year 2023 consolidated adjusted income from operations per share of at least $24.75.","Prior guidance was provided on Nov 2, 2023; reaffirmation made during investor meetings starting Dec 4.","Adjusted income from operations is a non-GAAP measure excluding investment results, intangible amortization, and special items.","Management is not providing a reconciliation to GAAP due to uncertainty in certain components."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":264705,"accession_number":"0000950159-23-000272","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2023-11-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cigna Q3 adj EPS $6.77, revenue $49.0B; raises FY2023 adj EPS outlook to at least $24.75","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 shareholders' net income $1.4B ($4.74/share) vs $2.8B ($8.97) a year ago; adjusted income from ops $2.0B ($6.77/share) up 8% YoY.","Total revenues $49.0B, up 8% YoY; adjusted revenues $49.1B; Evernorth adj rev $38.6B (+8%), Cigna Healthcare adj rev $12.8B (+14%).","FY2023 outlook raised: adjusted EPS at least $24.75 (from at least $24.70), revenue at least $192B (from $190B), cash from ops at least $10.5B (from $9.5B).","Medical customers 19.6M, up 9% vs Dec 2022; YTD share repurchases 7.7M shares for ~$2.2B; debt-to-cap 40.5% vs 41.9% at June 30."],"consensus_eps_estimate":null,"consensus_eps_actual":13.89,"consensus_revenue_estimate":null,"consensus_revenue_actual":144151000000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":281945,"accession_number":"0000950159-23-000267","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2023-09-15T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Cigna expands roles and raises compensation for two EVPs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Noelle K. Eder (EVP Technology & Operations) and Nicole S. Jones (EVP, CAO & GC) received expanded responsibilities.","Jones now also leads Human Resources; Eder leads new Technology and Operations function.","Base salary for each raised to $850,000; annual incentive target $900,000; LTI target $3,250,000.","Changes effective September 14, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":281944,"accession_number":"0000950159-23-000258","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2023-09-11T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Cigna reaffirms FY2023 adjusted EPS guidance of at least $24.70","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Management expects to reaffirm full-year 2023 consolidated adjusted income from operations of at least $24.70 per share.","Guidance was previously disclosed on August 3, 2023; no changes to outlook are announced.","Adjusted income from operations is a non-GAAP measure; reconciliation to GAAP net income not provided without unreasonable effort."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":281943,"accession_number":"0000950159-23-000227","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2023-08-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cigna Q2 adjusted EPS $6.13, revenue up 7% to $48.6B; raises FY revenue guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Adjusted income from operations $1.82B ($6.13/share) vs $1.97B ($6.20) YoY, reflecting absence of divested businesses.","Total revenue $48.6B (+7% YoY) driven by Evernorth and Cigna Healthcare growth.","FY 2023 adjusted revenue outlook raised to at least $190B (+$2B); adjusted EPS reaffirmed at least $24.70.","Total medical customers reached 19.5M (+1.5M or +8% from Dec 2022), driven by U.S. Commercial and Medicare Advantage.","FY 2023 cash flow from operations outlook raised to at least $9.5B (+$500M)."],"consensus_eps_estimate":null,"consensus_eps_actual":9.15,"consensus_revenue_estimate":null,"consensus_revenue_actual":95103000000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":300950,"accession_number":"0000950159-23-000204","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2023-06-05T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Cigna reaffirms FY2023 adjusted EPS outlook of at least $24.70","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Reaffirms full-year 2023 consolidated adjusted income from operations per share of at least $24.70, unchanged from May 5 guidance.","Outlook will be reiterated during investor meetings over the next several weeks.","Adjusted income from operations excludes realized investment results, amortization of intangibles, and special items."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":300949,"accession_number":"0000950159-23-000159","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2023-05-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cigna Q1 EPS $5.41 (adj.) on $46.5B revenue; raises FY adj. EPS outlook to at least $24.70","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Shareholders' net income $1.3B ($4.24 GAAP EPS); adjusted income from ops $1.6B ($5.41), down from $1.9B in Q1 2022 primarily from divested businesses.","Total revenues $46.5B, up 6% YoY; Evernorth revenues $36.2B (+8%), Cigna Healthcare $12.7B (+12%).","2023 outlook raised: adjusted income from ops per share at least $24.70 (up $0.10), revenues at least $188B. Cigna Healthcare MCR guided 81.5%-82.3%.","Medical customers 19.5M (+8% from Dec 2022); pharmacy customers 98.7M (+5%). Debt-to-cap ratio 42.2%.","Year-to-date share repurchases of 3.7M shares for ~$1.1B."],"consensus_eps_estimate":null,"consensus_eps_actual":4.24,"consensus_revenue_estimate":null,"consensus_revenue_actual":46517000000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":300948,"accession_number":"0000950159-23-000157","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2023-05-01T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cigna appoints Dr. Philip Ozuah to Board of Directors effective June 1, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Philip Ozuah appointed independent director on Cigna Board effective June 1, 2023.","Ozuah is President & CEO of Montefiore Medicine, overseeing 13 hospitals and 300 ambulatory sites.","He brings deep expertise in value-based care and population health from 32 years at Montefiore.","Over 60% of Cigna's Board has been refreshed in the past five years to enhance diversity.","Ozuah will serve on the People Resources and Compliance Committees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":300947,"accession_number":"0000950159-23-000155","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2023-04-28T23:59:59+00:00","items":["1.01","8.01","2.03","9.01"],"status":"ready","headline":"Cigna enters $4B five-year and $1B 364-day revolving credit facilities","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $4.0B five-year and $1.0B 364-day revolver replace existing credit facilities.","Combined capacity can be increased by up to $1.5B, for a maximum of $6.5B.","Interest rates based on SOFR plus margin tied to Cigna's senior unsecured credit ratings.","Covenant limits leverage ratio to ≤0.60:1 (or 0.65:1 for four quarters post large acquisition).","Facilities support general corporate purposes; JPMorgan, BofA, Citi, Morgan Stanley, Wells Fargo are joint lead arrangers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":300946,"accession_number":"0000950159-23-000152","cik":1739940,"company_name":"Cigna Group","ticker":"CI","form_type":"8-K","filed_at":"2023-04-27T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Cigna shareholders elect all 11 directors, approve say-on-pay and charter amendment at 2023 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 11 director nominees elected; David M. Cordani received 235M votes for, 15.5M against.","Say-on-pay approved with 221.4M votes for (29.7M against).","Annual frequency for say-on-pay votes adopted with 247.5M votes for one year.","Charter amendment limiting officer liability approved with 222.9M votes for (28.4M against).","Shareholder proposal on special meetings failed: 117.4M for, 133.6M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":75680077082.28755,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2023-04-27T23:59:59+00:00|300946"}